{"id":"tp-42630","type":"article-newspaper","title":"Lilly Says Retatrutide Reduced A1C and Produced Weight Loss in Phase 3 Trial","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/42630","datePublished":"2026-10-28T13:43:45.000Z","dateModified":"2026-10-28T13:43:45.000Z","language":"en","abstract":"The company said the treatment reduced A1C, a biomarker associated with diabetes, alongside weight loss.","section":"Business","references":[]}